Inducible transgenics. New lessons on events governing the induction and commitment in mammary tumorigenesis

Breast Cancer Research

Volumn 3, Issue 4, 2001, Pages 209-212

  Hulit, J ^a   Di Vizio, D ^a   Pestell, R G ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

C Myc; Inducible transgenics; Mammary oncogenes; Ras

Indexed keywords

MYC PROTEIN; RAS PROTEIN; TETRACYCLINE;

ANIMAL CELL; ANIMAL TISSUE; BREAST CANCER; BREAST EPITHELIUM; BREAST TUMOR; CARCINOGENESIS; CORRELATION FUNCTION; EPITHELIUM CELL; GENE ACTIVITY; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMARY GLAND; MOUSE; NONHUMAN; NOTE; ONCOGENE C MYC; ONCOGENE K RAS; ONCOGENE N RAS; ONCOGENE RAS; PHENOTYPE; POINT MUTATION; RODENT; TISSUE SPECIFICITY; TRANSGENE; TUMOR REGRESSION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GENES, RAS; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MICE; RATS;

EID: 0034936765     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr297     Document Type: Note

References (27)

1. Cell-cycle dysregulation in breast cancer: Breast cancer therapies targeting the cell cycle
2. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations
3. Reversibility of acute B-cell leukaemia induced by BCR-ABL1
4. Essential role for oncogenic ras in tumour maintenance
5. Reversible tumorigenesis by MYC in hematopoietic lineages
6. Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion
7. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo
8. Dual regulation of proliferation and apoptosis: C-myc in bitransgenic murine mammary tumor models
9. A matter of life and cell death
10. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
11. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal
12. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB
13. NF-κB is a target of AKT in anti-apoptotic PDGF signaling
14. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
15. MYC oncogenes and human neoplastic disease
16. Creation of human tumour cells with defined genetic elements
17. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
18. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes
19. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening
20. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability
21. Transient excess of MYC activity can elicit genomic instability and tumorigenesis
22. Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression
23. Cyclins D1 and D2 mediate Myc-induced proliferation via sequestration of p27Kip1 and p21Cip1
24. Myc activates telomerase
25. Risky immortalization by telomerase
26. Mechanisms of apoptosis by c-Myc
27. Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: Transrepression correlates with acceleration of apoptosis